Solpadeine
_(6162)_(14781295841).jpg)
Solpadeine is the brand name of a range of analgesic medication containing various amounts of paracetamol, ibuprofen, caffeine and codeine, currently made by Omega Pharma.[1] The range was previously made by GlaxoSmithKline, which sold its portfolio of over-the-counter drugs to Omega Pharma in 2012.[2]
In the United Kingdom there are four different medicines using the Solpadeine name, with no common active ingredient between them. The range includes:
- Solpadeine Headache, containing paracetamol with caffeine
- Solpadeine Plus, a compound analgesic containing paracetamol and codeine (co-codamol), with caffeine
- Solpadeine Max, a compound analgesic containing paracetamol and codeine (with a higher codeine content than Solpadeine Plus), but without the caffeine
- Solpadeine Migraine, a compound analgesic containing ibuprofen and codeine
In Australia it is marketed as Panadeine.[3]
External links
References
- ^ "Omega Pharma - Solpadeine". Omega-pharma.pl. Retrieved 2013-09-14.
- ^ Corporate Comms (2012-03-15). "GlaxoSmithKline provides further update on divestment of non-core over-the-counter (OTC) brands". Us.gsk.com. Retrieved 2013-09-14.
- ^ "Panadeine - GlaxoSmithKline New Zealand". Gsk.co.nz. 2008-11-17. Retrieved 2013-09-14.
| Subsidiaries |
| ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Predecessors, acquisitions | |||||||||
| Products |
| ||||||||
| People |
| ||||||||
| Litigation | |||||||||
| Other | |||||||||
 | This analgesic-related article is a stub. You can help Wikipedia by expanding it. |